Freenome, Inc. Common stock (FRNM) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$11.58

From 52W high−33.96%

Volume754934.00

Market cap$1.21B

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataNov 4, 2026

Open

$11.58

From 52W high

−33.96%

Volume

754934.00

Market cap

$1.21B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

31.4

MomentumView details →

1D Return

−1.48%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−1.48%

YTD Return

—

1Y Return

—

RSI (14)

31.4

vs 50D SMA

−25.73%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Next earningsNov 10, 2026 →

Latest newsMore news →

FRNM announced the commercial availability of SimpleScreen Lung, a laboratory-developed test that screens for lung and colorectal cancer from one blood draw and can be ordered alone or alongside its FDA-approved SimpleScreen CRC test; SimpleScreen Lung itself has not been reviewed or approved by the FDA.15d ago

FRNM announced that it will present validation data on an updated version of its SimpleScreen CRC blood-based screening test at the ACG 2026 Annual Meeting in Nashville.24d ago

Similar companies

Morgan Stanley Direct Lending FundMSDL BOCOM International Holdings Company Limited03329.HK Bleichroeder Acquisition Corp. IIBBCQW China Industrial Securities International Financial Group Limited06058.HK B. Riley Financial, Inc. - 6.50RILYN B. Riley Financial, Inc. 5.50% Senior Notes Due 2026RILYK Find similar companies →

Latest newsMore news →

FRNM announced the commercial availability of SimpleScreen Lung, a laboratory-developed test that screens for lung and colorectal cancer from one blood draw and can be ordered alone or alongside its FDA-approved SimpleScreen CRC test; SimpleScreen Lung itself has not been reviewed or approved by the FDA.15d ago FRNM announced that it will present validation data on an updated version of its SimpleScreen CRC blood-based screening test at the ACG 2026 Annual Meeting in Nashville.24d ago